119 related articles for article (PubMed ID: 7201588)
1. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis.
Stefoski D; Schauf CL; McLeod BC; Haywood CP; Davis FA
Neurology; 1982 Aug; 32(8):904-7. PubMed ID: 7201588
[TBL] [Abstract][Full Text] [Related]
2. Neuroelectric blocking activity and plasmapheresis in amyotrophic lateral sclerosis.
Schauf CL; Antel JP; Arnason BG; Davis FA; Rooney MW
Neurology; 1980 Sep; 30(9):1011-3. PubMed ID: 6252513
[TBL] [Abstract][Full Text] [Related]
3. Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis.
Schauf CL; Schauf V; Davis FA; Mizen MR
Neurology; 1978 May; 28(5):426-30. PubMed ID: 306076
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis.
Vlaic S; Poalelungi V; Bălăeţ M; Purcărea VL; Bălăeţ C; Coculescu BI
J Med Life; 2017; 10(1):50-53. PubMed ID: 28255377
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
6. Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosis.
Bastiaans DE; van Uden IW; Ruiterkamp RA; de Jong BA
Ther Drug Monit; 2013 Feb; 35(1):1-3. PubMed ID: 23222689
[TBL] [Abstract][Full Text] [Related]
7. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
[TBL] [Abstract][Full Text] [Related]
8. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
Uchida A; Maida EM; Lenzhofer R; Micksche M
Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
12. Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis.
Medenica RD; Mukerjee S; Huschart T; Corbitt W
J Clin Apher; 1994; 9(4):216-21. PubMed ID: 7759466
[TBL] [Abstract][Full Text] [Related]
13. Neuroelectric blocking factors in multiple sclerosis and normal human sera.
Seil FJ; Leiman AL; Kelly JM
Arch Neurol; 1976 Jun; 33(6):418-22. PubMed ID: 938266
[TBL] [Abstract][Full Text] [Related]
14. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.
Faissner S; Nikolayczik J; Chan A; Hellwig K; Gold R; Yoon MS; Haghikia A
J Neurol; 2016 Jun; 263(6):1092-8. PubMed ID: 27039388
[TBL] [Abstract][Full Text] [Related]
15. [Plasmapheresis in multiple sclerosis].
Fuchs S; Pogglitsch H; Ladurner G; Lechner H
Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).
Höcker P; Stellamor V; Summer K; Mann M
Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange in multiple sclerosis.
Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
[No Abstract] [Full Text] [Related]
19. Trace elements and plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
Int J Artif Organs; 1991 Apr; 14(4):242-5. PubMed ID: 2060990
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
